EWA
VIR icon

EverSource Wealth Advisors’s Vir Biotechnology VIR Stock Holding History

EverSource Wealth Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8K Buy
1,544
+387
+33% +$3.08K ﹤0.01% 2741
2025
Q4 		$6.98K Buy
1,157
+50
+5% +$298 ﹤0.01% 2976
2025
Q3 		$6.32K Sell
1,107
-441
-28% -$2.25K ﹤0.01% 3044
2025
Q2 		$7.8K Buy
1,548
+1,237
+398% +$6.63K ﹤0.01% 2965
2025
Q1 		$2.02K Buy
311
+70
+29% +$622 ﹤0.01% 2927
2024
Q4 		$1.77K Buy
241
+71
+42% +$560 ﹤0.01% 2759
2024
Q3 		$1.27K Buy
170
+132
+347% +$1.15K ﹤0.01% 2663
2024
Q2 		$386 Buy
38
+3
+9% +$29 ﹤0.01% 2939
2024
Q1 		$296 Buy
+35
New +$356 ﹤0.01% 2778
2023
Q1 		– Sell
-20
Closed -$506 – 2551
2022
Q4 		$506 Buy
+20
New +$490 ﹤0.01% 2208

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return